Brendon Yee, PhD, professor and respiratory and sleep physician, Woolcock Institute of Medical Research, discusses the success of ALKS 2680, an investigational oral selective orexin 2 receptor ...
Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai.
This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.
Expert Rev Endocrinol Metab. 2008;3(5):577-592. Disclosure: The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or ...
Detecting danger is key to the survival and success of all species. Animal nervous and immune systems cooperate to optimize danger detection. Preceding studies have highlighted the benefits of ...
CircuitPython is a beginner friendly, open source version of Python for tiny, inexpensive computers called microcontrollers. Microcontrollers are the brains of many electronics including a wide ...
Department of Pharmacology, University of California, San Diego, La Jolla, California 92093, United States Biomedical Sciences Graduate Program, University of California, San Diego, La Jolla, ...
There's the IH injunction, which is under appeal at the Federal Circuit. And briefing for that ... So, I guess the question is, as you think about the orexin longer term, how are you thinking ...